Tirzepatide more effective in blood sugar control and body weight loss than semaglutide, shows meta-analysis
Source: Medical Xpress
A new meta-analysis combining 22 studies, to be presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October), shows that tirzepatide is superior to semaglutide for both control of blood sugar and in terms of amount of body weight lost by patients.